Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2013
15th World Conference on Lung Cancer
Access to all presentations that occurred during the 15th World Conference on Lung Cancer in Sydney, Australia.
Presentation Date(s):- October 27 - 30, 2013
- Total Presentations: 2517
-
+
P1.06 - Poster Session 1 - Prognostic and Predictive Biomarkers
- Type: Poster Session
- Track: Biology
- Presentations: 59
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.06-040 - The Bim Deletion Polymorphism profile and its relationship with TKIs Resistance in Chinese NSCLC Population
09:30 - 09:30 | Author(s): Y. Zhang
- Abstract
Loading...
-
+
P1.07 - Poster Session 1 - Surgery
- Type: Poster Session
- Track: Surgery
- Presentations: 48
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.07-028 - Thoracoscopic minimally invasive surgery for non-small cell lung cancer in patients with chronic obstructive pulmonary disease
09:30 - 09:30 | Author(s): F. Cui
- Abstract
Loading...
-
+
P1.10 - Poster Session 1 - Chemotherapy
- Type: Poster Session
- Track: Medical Oncology
- Presentations: 57
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.10-004 - Exploratory Subset Analysis in African Americans from the PointBreak Study (Randomized Phase 3 Pemetrexed + Carboplatin + Bevacizumab Followed by Maintenance Pemetrexed + Bevacizumab Versus Paclitaxel + Carboplatin + Bevacizumab followed by Maintenance Bevacizumab in Patients with Stage IIIB/ IV Nonsquamous Non-Small Cell Lung Cancer)
09:30 - 09:30 | Author(s): C. Reynolds
- Abstract
Loading... -
+
P1.10-013 - Nab-paclitaxel (Abraxane) based chemotherapy for pretreated elderly advanced NSCLC patients: an open-label, single center, randomized phase II trial
09:30 - 09:30 | Author(s): L. Lin
- Abstract
Loading... -
+
P1.10-033 - Safety and Resource Use in PRONOUNCE: A randomized, phase 3, open-label study of Pemetrexed plus Carboplatin with maintenance Pemetrexed (PemC) and Paclitaxel plus Carboplatin plus Bevacizumab with maintenance Bevacizumab (PCB) in patients with advanced non-squamous (NS) non-small-cell lung cancer (NSCLC)
09:30 - 09:30 | Author(s): H.J. Ross
- Abstract
Loading... -
+
P1.10-034 - Weight Gain as a Prognostic Factor on Patient Outcomes
In Advanced, Nonsquamous, Non-small Cell Lung Cancer09:30 - 09:30 | Author(s): J.D. Patel
- Abstract
Loading... -
+
P1.10-055 - Treatment rationale and study design for an open-label randomized phase II trial of gemcitabine and cisplatin with or without bevacizumab in EGFR wild-type non-squamous non-small-cell lung cancer
09:30 - 09:30 | Author(s): J. Li
- Abstract
Loading...
-
+
P1.11 - Poster Session 1 - NSCLC Novel Therapies
- Type: Poster Session
- Track: Medical Oncology
- Presentations: 45
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.11-027 - Phase I studies of HM781-36B, an irreversible pan-HER tyrosine kinase inhibitor (TKI) in patients with advanced solid tumor and the therapeutic potential in patients with advanced non-small cell lung cancer (NSCLC)
09:30 - 09:30 | Author(s): D. Kim
- Abstract
Loading...
-
+
P1.12 - Poster Session 1 - NSCLC Early Stage
- Type: Poster Session
- Track: Medical Oncology
- Presentations: 23
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.12-021 - Development and validation of a clinical prediction model for N2 lymph node metastasis in stage I non-small cell lung cancer
09:30 - 09:30 | Author(s): K. Chen
- Abstract
Loading...
-
+
P1.15 - Poster Session 1 - Thymoma
- Type: Poster Session
- Track: Thymoma & Other Thoracic Malignancies
- Presentations: 9
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.15-002 - Results and Prognostic Features of Recurrent Thymoma
09:30 - 09:30 | Author(s): C. Xu
- Abstract
Loading...
-
+
P1.22 - Poster Session 1 - Epidemiology, Etiology
- Type: Poster Session
- Track: Prevention & Epidemiology
- Presentations: 12
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.22-005 - A Prospective, Molecular Epidemiological Study of EGFR Mutations in Asian Patients with Advanced Non-Small-Cell Lung Cancer with Adenocarcinoma Histology (PIONEER study) - China Subset Analysis
09:30 - 09:30 | Author(s): Y. Shi
- Abstract
Loading...
-
+
O01 - Prognostic and Predictive Biomarkers I
- Type: Oral Abstract Session
- Track: Medical Oncology
- Presentations: 8
- Moderators:T. Mitsudomi
- Coordinates: 10/28/2013, 10:30 - 12:00, Parkside Auditorium, Level 1
-
+
O01.05 - EGFR wild-type NSCLC patients with high miR-200c expression can benefit from EGFR-TKI
11:15 - 11:25 | Author(s): J. Li
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
O04 - Molecular Pathology I
- Type: Oral Abstract Session
- Track: Pathology
- Presentations: 8
- Moderators:I.I. Wistuba
- Coordinates: 10/28/2013, 10:30 - 12:00, Parkside Ballroom A, Level 1
-
+
O04.03 - Oncogene Mutations and Novel Transcript Fusions in Lung Adenocarcinoma from Never Smokers
10:50 - 11:00 | Author(s): J. Jen
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MO09 - Mesothelioma I
- Type: Mini Oral Abstract Session
- Track:
- Presentations: 14
- Moderators:K. Suzuki
- Coordinates: 10/28/2013, 16:15 - 17:45, Bayside 204 A+B, Level 2
-
+
MO09.13 - Comparison of Three Radiographic Tumor Volume Estimation Techniques for Malignant Pleural Mesothelioma: Their Correlation with Each Other, Actual Measured Intraoperative Tumor Volumes, and Survival
17:25 - 17:30 | Author(s): J. Friedberg
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
